Your session is about to expire
← Back to Search
Motiva Implants® for Breast Enhancement
Study Summary
This trial looks at the safety and effectiveness of a new breast implant.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have enough tissue to cover the implant.I have an infection or abscess.I am willing to have an MRI if my doctor recommends it.I am not on medication that affects blood clotting or increases surgery risks.I have a condition like lupus, scleroderma, or rheumatoid arthritis.I am seeking breast surgery, either for augmentation or reconstruction.I have a condition like severe obesity, diabetes, or heart disease that could make surgery risky.I am HIV positive.I have been diagnosed with anaplastic large cell lymphoma.I am genetically female.I am considering a breast surgery, either for the first time or as a revision.I have enough tissue to cover the breast implant.I am willing to have an MRI if my doctor recommends it.My tissue is damaged or unsuitable for procedures due to previous conditions like radiation damage.I have pre-cancerous breast conditions or BRCA mutations without having both breasts removed.I am genetically female.I am seeking or have had breast surgery for augmentation or reconstruction.
- Group 1: Revision Reconstruction
- Group 2: Primary Breast Reconstruction
- Group 3: Revision Augmentation
- Group 4: Primary Breast Augmentation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals beneath the age of 25 able to participate in this experiment?
"In agreement with the regulations of this clinical trial, participants must be aged 18 and above whilst not exceeding 70 years old."
In which venues is this clinical research being conducted?
"There are 19 medical centres offering this research, with Northwestern Specialists in Plastic Surgery in Chicago, Cleaveland Clinic in Cleveland and Peacehealth Medical Group Plastic Surgery in Vancouver among them."
Are there any vacancies in this clinical trial that could be filled by participants?
"According to the information posted on clinicaltrials.gov, this study is no longer actively seeking participants. It was initially published in April 2018 and last updated late August 2022. Nonetheless, there are two other trials that are currently recruiting patients for enrolment."
What criteria must individuals fulfill to qualify for this research experiment?
"This clinical trial is enrolling 800 individuals, aged 18 to 70 years old. These participants must have a breast implant and enough tissue coverage for the device as well as meet genetic female criteria."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Most responsive sites:
- Rafael Gottenger, MD Plastic Surgery: < 24 hours
- Westlake Cosmetic Surgery Center: < 48 hours
Average response time
- < 2 Days
Typically responds via
Share this study with friends
Copy Link
Messenger